CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Titan Pharmaceuticals Inc Company Snapshot
Titan Pharmaceuticals Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Titan Pharmaceuticals Inc with three other companies in this sector in UNITED STATES : LogicBio Therapeutics Inc (2020 sales of $3.45 million of which 100% was BIOLOGICAL PRODUCTS), Avidity Biosciences Inc ($6.79 million of which 100% was Pharmaceutical), and Vaxart Inc ($4.05 million of which 100% was pharmaceutical).

Sales Analysis. Sales levels dropped significantly in the second quarter of 2021 versus the previous year's second quarter. During the second quarter of 2021, sales at Titan Pharmaceuticals Inc totalled $445,000.00 . This is a drop of 66.4% from the $1.33 million in sales at the company during the second quarter in 2020. During the first two quarters of 2021, sales totalled $1.13 million, which is 57.6% lower than through the first two quarters of 2020. Titan Pharmaceuticals Inc reported sales of $4.84 million for the year ending December of 2020. This represents an increase of 34.0% versus 2019, when the company's sales were $3.61 million. Despite this increase, sales are still well below the level achieved in 2018, when Titan Pharmaceuticals Inc reported sales of $6.62 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Titan Pharmaceuticals Inc
  Stock Performance Chart for Titan Pharmaceuticals Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (10/22/2021): 1.75
(Figures in U.S. Dollars)
1 Week -1.7%   13 Weeks -10.7%  
4 Weeks -23.2%   52 Weeks -57.5%  
 
Titan Pharmaceuticals Inc Key Data:
  Ticker: TTNP Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2020 Sales 4,838,000
(Year Ending Jan 2021).
Employees: 12
  Currency: U.S. Dollars Market Cap: 17,262,000
  Fiscal Yr Ends: December Shares Outstanding: 9,864,000
  Share Type: Common Closely Held Shares: 687,859
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.